L’altra metà.. Del diabete

Journal title SALUTE E SOCIETÀ
Author/s Stefano Del Prato, Cristina Bianchi
Publishing Year 2014 Issue 2014/1
Language Italian Pages 17 P. 58-74 File size 902 KB
DOI 10.3280/SES2014-001006
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Obesity, physical inactivity and unhealthy diet are common risk factors in men and women for the development of diabetes. Yet some physiological and pathological conditions are unique to the women and these conditions can increase their risk of developing diabetes and its complications. In particular, the metabolic status during pregnancy may have important implications on their own well being as well as the one of their children. Therefore, it is necessary that these feature conditions become the object of screenings in order to identify women at high risk and implement effective preventative maneuvers. Though the quality and intensity of diabetes care in women does not appear to be inferior to that of men, their therapeutic response remains limited. Better understanding of gender-related pathophysiological, diagnostic, and therapeutic responses is needed in order to design specific approaches to improve outcomes in women. Women must consider the opportunity to change their eating habits and lifestyle in general, in an attempt to preserve themselves and their family.

Keywords: Woman, diabetes, gender, cardiovascular risk, prevention, life style

  1. American Diabetes Association (2013). Standards of Medical Care in Diabetes.Diabetes Care, 36, Suppl 1: S11-66, DOI: 10.2337/dc13-S01
  2. Bellamy L., Casas J.P., Hingorani A.D., Williams D. (2009). Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet, 373: 1773-1779, DOI: 10.1016/S0140-6736(09)60731-
  3. Boomsma C.M., Eijkemans M.J., Hughes E.G., Visser G.H., Fauser B.C., Macklon N.S. (2006). A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update, 12: 673-683
  4. Booth G.L., Kapral M.K., Fung K., Tu J.V. (2006). Relation between age and cardiovascular disease in men and women with diabetes compared with nondiabetic people: a population-based retrospective cohort study. Lancet, 368(9529): 29-36.
  5. Colditz G.A., Willett W.C., Rotnitzky A., Manson J.E. (1995). Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med, 122: 481-486
  6. Dabadghao P., Roberts B.J., Wang J., Davies M.J., Norman R.J. (2007). Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust, 187: 328-331
  7. de Vegt F., Dekker J.M., Jager A., Hienkens E., Kostense P.J., Stehouwer C.D., Nijpels G., Bouter L.M., Heine R.J. (2001). Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA, 285: 2109-2113
  8. Dunaif A., Segal K.R., Futterweit W., Dobrjansky A. (1989). Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38: 1165-1174
  9. Dunaif A. (1995). Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med, 98: 33S39S
  10. Dyck R.F., Klomp H., Tan L. (2001). From “thrifty genotype” to “hefty fetal phenotype”: the relationship between high birthweight and diabetes in Saskatchewan Registered Indians. Can J Public Health, 92: 340-344
  11. Ehrmann D.A., Barnes R.B., Rosenfield R.L., Cavaghan M.K., Imperial J. (1999). Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care, 22: 141-146
  12. Ferrara A., Mangione C.M., Kim C., Marrero D.G., Curb D., Stevens M., Selby J.V. (2008). Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes. Diabetes Care, 31: 69-74
  13. Franco O.H., Steyerberg E.W., Hu F.B., Mackenbach J., Nusselder W. (2007). Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med, 167: 1145-51
  14. Franzini L., Ardigò D., Cavalot F., Miccoli R., Rivellese A.A., Trovati M., Zavaroni I., Vaccaro O. (2013). Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: Results from the MIND.IT Study Group of the Italian Society of Diabetology. Nutr Metab Cardiovasc Dis, 23(3): 235-41
  15. Gouni-Berthold I., Berthold H.K., Mantzoros C.S., Böhm M., Krone W. (2008). Sex Disparities in the Treatment and Control of Cardiovascular Risk Factors in Type 2 Diabetes. Diabetes Care, 31: 1389-91
  16. Gregg E.W., Gu Q., Cheng Y.J., Narayan K.M., Cowie C.C. (2007). Mortality trends in men and women with diabetes. 1971-2000. Ann Intern Med, 147: 149-155
  17. Harder T., Rodekamp E., Schellong K., Dudenhausen J.W., Plagemann A. (2007). Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol, 165: 849-857
  18. Hiltunen L. (2005). Ten-year mortality and glucose tolerance status in an elderly Finnish population. Diabetes Research and Clinical Practice, 69: 81-87
  19. Hofman P.L., Regan F., Jackson W.E., Jefferies C., Knight D.B., Robinson E.M., Cutfield W.S. (2004). Premature birth and later insulin resistance. N Engl J Med, 351: 2179-2186
  20. Howard B.V., Cowan L.D., Go O., Welty T.K., Robbins D.C., Lee E.T. (1998). Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the Strong Heart Study. Diabetes Care, 21: 1258-65
  21. Hu F.B., Li T.Y., Colditz G.A., Willett W.C., Manson J.E. (2003). Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA, 289(14): 1785-1791
  22. Hu F.B., Manson J.E., Stampfer M.J., Colditz G., Liu S., Solomon C.G., Willett W.C. (2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med, 345(11): 790-797
  23. ISMEA (Istituto di Servizi per il Mercato Agricolo Alimentare). Rapporto sui consumi alimentari in Italia. Consultabile su www.ismea.it/flex/cm/pages/ServeBLOB.php/L/IT/IDPagina/941
  24. Kim C., Newton K.M., Knopp R.H. (2002). Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care, 25: 1862-1868
  25. Knowler W.C., Barrett-Conner E.R., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., Nathan D.M.; Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 346: 393-403
  26. Legato M.J., Gelzer A., Goland R., Ebner S.A., Rajan S., Villagra V., Kosowski M. (2006). Writing Group for The Partnership for Gender-Specific Medicine. Gender-specific care of the patient with diabetes: review and recGender-specific care of the patient with diabetes: review and recommendations. Gend Med, Jun, 3(2):131-58
  27. Levitan E.B., Song Y., Ford E.S., Liu S. (2004). Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med, 164(19): 2147-2155
  28. Massi-Benedetti M., CODE-2 advisory board (2002). The cost of diabetes type II in Europe: the CODE-2 study. Diabetologia, 45: S1-S4
  29. Meigs J.B., Nathan D.M., D’Agostino R.B. Sr., Wilson P.W., for the Framingham Offspring Study (2002). Fasting and the postchallenge glycemia and cardiovascular disease risk: The Framingham Offspring Study. Diabetes Care, 25:1845-1850
  30. Moran L.J., Misso M.L., Wild R.A., Norman R.J. (2010). Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update, 16(4): 347-63
  31. Pan W.H., Cedres L.B., Liu K., Dyer A., Schoenberger J.A., Shekelle R.B., Stamler R., Smith D., Collette P., Stamler J. (1986). Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol, 123: 504-516
  32. Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., Hu Z.X., Lin J., Xiao J.Z., Cao H.B., Liu P.A., Jiang X.G., Jiang Y.Y., Wang J.P., Zheng H., Zhang H., Bennett P.H., Howard B.V. (1997). Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care, 20: 537-544
  33. Penno G., Solini A., Bonora E., Fondelli C., Orsi E., Zerbini G., Trevisan R., Vedovato M., Gruden G., Laviola L., Nicolucci A., Pugliese G.; the Renal Insufficiency And Cardiovascular Events (RIACE) study, group (2013). Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. J Intern Med, DOI: 10.1111/joim.12073[Epubaheadofprint
  34. Perreault L., Ma Y., Dagogo-Jack S., Horton E., Marrero D., Crandall J., Barrett-Connor E., Diabetes Prevention Program (2008). Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program. Diabetes Care, 31: 1416-21
  35. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. (2002). Comparison of Creactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 347: 1557-65
  36. Robinson S., Kiddy D., Gelding S.V., Willis D., Niththyananthan R., Bush A., Johnston D.G., Franks S. (1993). The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf), 39: 351-355
  37. Salley K.E., Wickham E.P., Cheang K.I., Essah P.A., Karjane N.W., Nestler J.E. (2007). Glucose intolerance in polycystic ovary syndrome - a position statement of the Androgen Excess Society. J Clin Endocrinol Metab, 92: 4546-4556
  38. Shaw J.E., Sicree R.A., Zimmet P.Z. (2010). Global estimates of prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87: 4-14
  39. Tomlinson J., Millward A., Stenhouse E., Pinkney J. (2010). Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced? Diabet Med, 27(5): 498-515
  40. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., Keinanen-Kiukaanniemi S., Laakso M., Louheranta A., Rastas M., Salminen V., Uusitupa M. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med, 344: 1343-50
  41. Valdez R., Athens M.A., Thompson G.H., Bradshaw B.S., Stern M.P. (1994). Birthweight and adult health outcomes in a biethnic population in the USA. Diabetologia, 37: 624-631
  42. Vazquez G., Duval S., Jacobs Jr D.R., Silventoinen K. (2007). Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev, 29: 115-128

Stefano Del Prato, Cristina Bianchi, L’altra metà.. Del diabete in "SALUTE E SOCIETÀ" 1/2014, pp 58-74, DOI: 10.3280/SES2014-001006